Crossmark

Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098 an open-label randomized comparative effectiveness trial of extended-release buprenorphine versus treatment as usual on post-hospital treatment engagement for hospitalized patients with opioid use disorder

Crossref DOI link: https://doi.org/10.1186/s13722-024-00510-5

Published Online: 2024-12-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bart, Gavin

Barth, Kelly S.

Baukol, Paulette

Enns, Eva

Ghitza, Udi E.

Harris, Jacklyn

Jelstrom, Eve

Liebschutz, Jane M.

Magane, Kara M.

Voronca, Delia

Weinstein, Zoe M.

Korthuis, P. Todd
Funding

Funding for this research was provided by:

National Institute on Drug Abuse (UG1DA040316, UG1DA013727, UG1DA015815)
License Information

Text and Data Mining valid from 2024-12-02

Version of Record valid from 2024-12-02
More Information

Article History

Received: 29 July 2024

Accepted: 28 October 2024

First Online: 2 December 2024

Declarations

:

: The study protocol was approved by Advarra (Protocol number Pro00047336), a commercial Institutional Review Board.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below